Israeli Technology Founders Speak: Conversations with Successful Israeli Hitech and Biotech Entrepreneurs
«
»
Alon Ben-Noon of NeuroSense Therapeutics
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on August 29, 2023 17:08 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 337501904 series 3382134
Nội dung được cung cấp bởi Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được tải lên và cung cấp trực tiếp bởi Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm hoặc đối tác nền tảng podcast của họ. Nếu bạn tin rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không được phép, bạn có thể làm theo quy trình được nêu tại đây https://vi.player.fm/legal.
Alon Ben-Noon is the CEO and co-founder of NeuroSense Therapeutics, a clinical stage drug development company offering ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. Avraham Hermon sat down with Alon in the NeuroSense offices in Herzliya. They discussed the inspiration for creating a new ALS treatment, how to create results using a small team, raising money, dealing with investors, the mentality of a startup founder, the role of patents in biotech companies and much more. Do you have a great innovation? We'd love to hear from you. Contact us by going to jmbdavis.com/startup/contact. Learn more at jmbdavis.com and jmbdavis.com/startup. Also available at https://soundcloud.com/jmbdavis/jeff-gabbay-of-argaman-technologies. Listen to all of the episodes at https://jmbdavis.com/podcast.
…
continue reading
28 tập
Chia sẻ
))
